本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Atea Pharmaceuticals, Inc.

2.85
-0.1400-4.68%
盤後2.850.00000.00%16:10 EDT
成交量:34.80萬
成交額:99.96萬
市值:2.44億
市盈率:-1.43
高:2.98
開:2.96
低:2.81
收:2.99
資料載入中...

公司資料

公司名字:
Atea Pharmaceuticals, Inc.
交易所:
NASDAQ
成立時間:
2012
員工人數:
56
公司地址:
225 Franklin Street,Suite 2100,Boston,Massachusetts,United States
郵編:
02110
電話:
傳真:
- -
簡介:
Atea Pharmaceuticals, Inc.於2012年7月註冊成立,並於2014年3月開始主要運營。該公司是一家臨床階段的生物製藥公司,利用對抗病毒藥物開發、藥物化學、生物學、生物化學和病毒學的深刻理解,發現和開發新型口服候選產品,以治療嚴重的病毒性疾病。

董事

名稱
職位
Jean Pierre Sommadossi
President and Chief Executive Officer and Chairman of the Board of Director
Andrew Hack
Director
Barbara Duncan
Director
Bruce Polsky
Director
Bruno Lucidi
Director
Franklin Berger
Director
Isaac Cheng
Director
Polly A. Murphy
Director

股東

名稱
職位
Jean Pierre Sommadossi
President and Chief Executive Officer and Chairman of the Board of Director
Andrea Corcoran
Chief Financial Officer, Executive Vice President, Legal and Secretary
Wayne Foster
Senior Vice President, Finance and Administration
Janet Hammond
Chief Development Officer
John Vavricka
Chief Commercial Officer
Maria Arantxa Horga
Acting Chief Medical Officer